help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DOUGLAS, W. W.
Right arrow Articles by RYU, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DOUGLAS, W. W.
Right arrow Articles by RYU, J. H.

Am. J. Respir. Crit. Care Med., Volume 164, Number 7, October 2001, 1182-1185

Polymyositis-Dermatomyositis-associated Interstitial Lung Disease

WILLIAM W. DOUGLAS, HENRY D. TAZELAAR, THOMAS E. HARTMAN, ROBERT P. HARTMAN, PAUL A. DECKER, DARRELL R. SCHROEDER, and JAY H. RYU

Division of Pulmonary and Critical Care Medicine, Division of Anatomic Pathology, Department of Diagnostic Radiology, and Section of Biostatistics, Mayo Clinic, Rochester, Minnesota

We report findings in 70 patients with both diffuse interstitial lung disease and either polymyositis (PM) or dermatomyositis (DM). Initial presentations were most commonly either musculoskeletal (arthralgias, myalgias, and weakness) or pulmonary (cough, dyspnea, and fever) symptoms alone; in only 15 patients (21.4%) did both occur simultaneously. Pulmonary disease usually took the form of acute to subacute antibiotic-resistant community-acquired pneumonia. Chest radiographs and computed tomography most commonly demonstrated bilateral irregular linear opacities involving the lung bases; occasionally consolidation was present. Jo-1 antibody was present in 19 (38%) of 50 patients tested. Synchronous associated malignancy was present in 4 of 70 patients (5.7%). Surgical lung biopsies disclosed nonspecific interstitial pneumonia (NSIP) in 18 of 22 patients (81.8%), organizing diffuse alveolar damage (DAD) in 2, bronchiolitis obliterans organizing pneumonia (BOOP) in 1, and usual interstitial pneumonia (UIP) in 1. Treatment usually included prednisone in 40-60 mg/d dosages for initial control, followed by lower dose prednisone plus an immunosuppressive agent such as azathioprine or methotrexate for disease suppression. Survival was significantly better than that observed for historical control subjects with idiopathic UIP, and was more consistent with survival previously reported in idiopathic NSIP. There was no difference in survival between Jo-1 positive and Jo-1 negative groups.




This article has been cited by other articles:


Home page
 ThoraxHome page
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax, September 1, 2008; 63(Suppl_5): v1 - v58.
[Full Text] [PDF]

Home page
 Cleveland Clinic Journal of MedicineHome page
R. M. TALIERCIO and J. CHAPMAN
The Clinical Picture: Dyspnea, arthralgias, and muscle weakness
Cleveland Clinic Journal of Medicine, July 1, 2008; 75(7): 540 - 542.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
G. E. Tzelepis, S. P. Toya, and H. M. Moutsopoulos
Occult connective tissue diseases mimicking idiopathic interstitial pneumonias
Eur. Respir. J., January 1, 2008; 31(1): 11 - 20.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Guglielmi, T. M. Merz, M. Gugger, C. Suter, and L. P. Nicod
Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus
Eur. Respir. J., January 1, 2008; 31(1): 213 - 217.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
I Tillie-Leblond, M Wislez, D Valeyre, B Crestani, A Rabbat, D Israel-Biet, M Humbert, L J Couderc, B Wallaert, and J Cadranel
Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset
Thorax, January 1, 2008; 63(1): 53 - 59.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Powell, B. Kendall, R. Wernick, and J. E. Heffner
A 34-Year-Old Man With Amyopathic Dermatomyositis and Rapidly Progressive Dyspnea With Facial Swelling
Chest, November 1, 2007; 132(5): 1710 - 1713.
[Full Text] [PDF]

Home page
 ThoraxHome page
R. du Bois and T. E King Jr
Challenges in pulmonary fibrosis {middle dot} 5: The NSIP/UIP debate
Thorax, November 1, 2007; 62(11): 1008 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. S. Kim and S. Nagai
Idiopathic Nonspecific Interstitial Pneumonia: An Unrecognized Autoimmune Disease?
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 632 - 633.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. W. Kinder, H. R. Collard, L. Koth, D. I. Daikh, P. J. Wolters, B. Elicker, K. D. Jones, and T. E. King Jr.
Idiopathic Nonspecific Interstitial Pneumonia: Lung Manifestation of Undifferentiated Connective Tissue Disease?
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 691 - 697.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D. C. Knockaert
Cardiac involvement in systemic inflammatory diseases
Eur. Heart J., August 1, 2007; 28(15): 1797 - 1804.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
J. H. Ryu, C. E. Daniels, T. E. Hartman, and E. S. Yi
Diagnosis of Interstitial Lung Diseases
Mayo Clin. Proc., August 1, 2007; 82(8): 976 - 986.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
I-N. Park, D. S. Kim, T. S. Shim, C.-M. Lim, S. D. Lee, Y. Koh, W. S. Kim, W. D. Kim, S. J. Jang, and T. V. Colby
Acute Exacerbation of Interstitial Pneumonia Other Than Idiopathic Pulmonary Fibrosis
Chest, July 1, 2007; 132(1): 214 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. H. Park, D. S. Kim, I-N. Park, S. J. Jang, M. Kitaichi, A. G. Nicholson, and T. V. Colby
Prognosis of Fibrotic Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease-related Subtypes
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 705 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
Y. Yamasaki, H. Yamada, M. Yamasaki, M. Ohkubo, K. Azuma, S. Matsuoka, Y. Kurihara, H. Osada, M. Satoh, and S. Ozaki
Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis
Rheumatology, January 1, 2007; 46(1): 124 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
V. Cottin
Interstitial lung disease: are we missing formes frustes of connective tissue disease?
Eur. Respir. J., November 1, 2006; 28(5): 893 - 896.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Suda, T. Fujisawa, N. Enomoto, Y. Nakamura, N. Inui, T. Naito, D. Hashimoto, J. Sato, M. Toyoshima, H. Hashizume, et al.
Interstitial lung diseases associated with amyopathic dermatomyositis
Eur. Respir. J., November 1, 2006; 28(5): 1005 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J-F. Cordier
Cryptogenic organising pneumonia.
Eur. Respir. J., August 1, 2006; 28(2): 422 - 446.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. G. Parambil, J. L. Myers, and J. H. Ryu
Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases.
Chest, August 1, 2006; 130(2): 553 - 558.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S J Bourke
Interstitial lung disease: progress and problems.
Postgrad. Med. J., August 1, 2006; 82(970): 494 - 499.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
F. J. Martinez
Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia.
Proceedings of the ATS, January 1, 2006; 3(1): 81 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. E. King Jr.
Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 268 - 279.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A Selva-O'Callaghan, M Labrador-Horrillo, X Munoz-Gall, X Martinez-Gomez, J Majo-Masferrer, R Solans-Laque, C P Simeon-Aznar, F Morell-Brotard, and M Vilardell-Tarres
Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients
Lupus, July 1, 2005; 14(7): 534 - 542.
[Abstract] [PDF]

Home page
 ChestHome page
H.-K. Lee, D. S. Kim, B. Yoo, J. B. Seo, J.-Y. Rho, T. V. Colby, and M. Kitaichi
Histopathologic Pattern and Clinical Features of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Chest, June 1, 2005; 127(6): 2019 - 2027.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
I. Ito, S. Nagai, M. Kitaichi, A. G. Nicholson, T. Johkoh, S. Noma, D. S. Kim, T. Handa, T. Izumi, and M. Mishima
Pulmonary Manifestations of Primary Sjogren's Syndrome: A Clinical, Radiologic, and Pathologic Study
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 632 - 638.
[Abstract] [Full Text] [PDF]

Home page
 ImagingHome page
N J Screaton and T Koh
Emphysema and smoking-related lung diseases
Imaging, October 1, 2004; 16(1): 50 - 60.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. R. Desai, S. Veeraraghavan, D. M. Hansell, A. Nikolakopolou, N. S. L. Goh, A. G. Nicholson, T. V. Colby, C. P. Denton, C. M. Black, R. M. du Bois, et al.
CT Features of Lung Disease in Patients with Systemic Sclerosis: Comparison with Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia
Radiology, August 1, 2004; 232(2): 560 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
S. Yaqub, K. G. Moder, and M. Q. Lacy
Severe, Reversible Pulmonary Hypertension in a Patient With Monoclonal Gammopathy and Features of Dermatomyositis
Mayo Clin. Proc., May 1, 2004; 79(5): 687 - 689.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. I. Latsi, R. M. du Bois, A. G. Nicholson, T. V. Colby, D. Bisirtzoglou, A. Nikolakopoulou, S. Veeraraghavan, D. M. Hansell, and A. U. Wells
Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends
Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 531 - 537.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
V. Cottin, F. Thivolet-Bejui, M. Reynaud-Gaubert, J. Cadranel, P. Delaval, P-J. Ternamian, J-F. Cordier, and and the Groupe d'Etudes et de Recherche sur les Ma
Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
Eur. Respir. J., August 1, 2003; 22(2): 245 - 250.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. R. Flaherty, T. V. Colby, W. D. Travis, G. B. Toews, J. Mumford, S. Murray, V. J. Thannickal, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al.
Fibroblastic Foci in Usual Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease
Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1410 - 1415.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. E. King Jr.
Nonspecific Interstitial Pneumonia and Systemic Sclerosis
Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1578 - 1579.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. Bouros, A. U. Wells, A. G. Nicholson, T. V. Colby, V. Polychronopoulos, P. Pantelidis, P. L. Haslam, D. A. Vassilakis, C. M. Black, and R. M. du Bois
Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome
Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1581 - 1586.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Tuberculosis, Lung Infections, Interstitial Lung Disease, and Socioeconomic Issues in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 631 - 641.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  ATS 2008 State of the Art Course